Results 181 to 190 of about 825,301 (311)

Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis

Hepatology, EarlyView., 2022
EtOH causes leaky gut allowing bacteria and PAMPs into the liver, resulting in hepatic inflammation and injury. We demonstrate that LPS induces STAT1‐mediated expression and phosphorylation of MLKL in macrophages and identify a novel function that myeloid MLKL translocates to phagosomes and lysosomes and regulates phagocytosis, which contributes to the
Xiaoqin Wu, Xiude Fan, Megan R. McMullen, Tatsunori Miyata, Adam Kim, Vai Pathak, Jianguo Wu, Le Z. Day, Josiah E. Hardesty, Nicole Welch, Jaividhya Dasarathy, Daniela S. Allende, Arthur J. McCullough, Jon M. Jacobs, Daniel M. Rotroff, Srinivasan Dasarathy, Laura E. Nagy   +16 more
wiley   +1 more source

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia. [PDF]

PLOS Glob Public Health
Walker JG, Tskhomelidze Schumacher I, Shadaker S, Gabunia T, Tohme RA, Abutidze A, Getia V, Vickerman P.   +7 more
europepmc   +1 more source

Hepatitis surveillance report [PDF]

Issued September 2000.With this issue, we are introducing a revised format for our description of surveillance data, which focuses on presentation of data with figure and tables and limited text.

core  

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Sex Disparities in Hepatitis C Treatment Initiation: Role of Universal Access to DAA in France (ANRS FANTASIO 2). [PDF]

Liver Int
Marcellin F, Ramier C, Brouard C, Di Beo V, Allier Y, Mourad A, Bureau-Stoltmann M, Sogni P, Deuffic-Burban S, Carrieri P, Rolland B, Bourliere M, Protopopescu C.   +12 more
europepmc   +1 more source

Hepatitis B: Are You At Risk? (Vietnamese)

Read the hepatitis B fact sheet in ...

core  

Long‐acting cabotegravir and rilpivirine in people with HIV receiving chronic anticoagulation: A real‐world case series

British Journal of Clinical Pharmacology, EarlyView.
Background Long‐acting intramuscular cabotegravir plus rilpivirine (LA‐CAB + RPV) is an effective maintenance antiretroviral regimen for virologically suppressed people with HIV. However, its use in individuals receiving chronic anticoagulation is limited by concerns regarding intramuscular bleeding risk, and real‐world data are scarce.
Montserrat Laguno, Berta Torres, Maria Martínez‐Rebollar, Paula Arreba, Octavi Roman, Roger LLobet, Leire Berrocal, Alberto Foncillas, Júlia Calvo, Abiu Sempere, Ivan Chivite, Elisa de Lazzari, Josep Mallolas, Ana González‐Cordón   +13 more
wiley   +1 more source

Hepatitis B: Are You At Risk? (Chinese)

Learn more about information for people at risk for hepatitis B ...

core   +1 more source

SEROLOGICAL CLEARANCE OF HBSAG IN CHRONIC HEPATITIS B: EXPERIENCE IN A UNIVERSITY HOSPITAL. [PDF]

Arq Gastroenterol
Amorim AGG, Costa APM.
europepmc   +1 more source

Hepatitis B: Are You At Risk? (Khmer)

Read the hepatitis B fact sheet in ...

core